Price Movement and Market Context
On 12 Mar 2026, Trident Texofab opened sharply lower, down 5.00% from the previous close, and traded steadily at Rs.49.82 throughout the session, which also represented the intraday low. This price point is notably distant from its 52-week high of Rs.379, underscoring the extent of the stock’s depreciation over the last year. The stock currently trades below all key moving averages – 5-day, 20-day, 50-day, 100-day, and 200-day – signalling a sustained bearish trend.
The broader market environment has also been challenging. The Sensex opened 494.06 points lower and is trading at 76,257.60, down 0.79%, continuing a three-week losing streak that has seen the index fall by 7.92%. Several indices, including the S&P Bse Dollex 30, S&P Bse Teck, and S&P Bse FMCG, also hit new 52-week lows today, reflecting widespread market weakness.
Financial Performance and Fundamental Metrics
Trident Texofab’s financial indicators reveal a mixed picture. The company reported its lowest quarterly net sales at Rs.25.74 crores in December 2025, indicating subdued revenue generation. Over the past year, the stock has delivered a negative return of 71.69%, starkly contrasting with the Sensex’s positive 3.06% return over the same period.
Long-term fundamental strength remains weak, with an average Return on Capital Employed (ROCE) of 6.88%, which is modest in comparison to industry standards. The company’s ability to service debt is constrained, as reflected by a high Debt to EBITDA ratio of 6.83 times, suggesting elevated leverage and financial risk.
Despite these challenges, the company’s valuation metrics show some relative attractiveness. The ROCE for the latest period stands at 7.4%, and the enterprise value to capital employed ratio is 1.2, indicating that the stock is trading at a discount relative to its peers’ historical valuations. Additionally, profits have risen by 122.5% over the past year, resulting in a PEG ratio of 0.5, which points to earnings growth outpacing the stock price decline.
Under the radar no more! This Large Cap from Cement is emerging from turnaround with solid fundamentals intact. Discover it while it's still relatively hidden!
- - Hidden turnaround gem
- - Solid fundamentals confirmed
- - Large Cap opportunity
Technical Indicators and Market Sentiment
Technical analysis of Trident Texofab’s stock reveals predominantly bearish signals. The Moving Average Convergence Divergence (MACD) indicator is bearish on a weekly basis and mildly bearish monthly. Bollinger Bands also indicate bearish trends on both weekly and monthly charts. The daily moving averages confirm the downward momentum, while the KST (Know Sure Thing) indicator is bearish weekly and mildly bearish monthly. Dow Theory assessments align with these findings, showing mild bearishness on both weekly and monthly timeframes.
Conversely, the Relative Strength Index (RSI) on a weekly basis shows a bullish signal, suggesting some short-term oversold conditions, though the monthly RSI does not provide a clear indication. Overall, the technical landscape supports the recent price weakness and the stock’s position below critical moving averages.
Comparative Performance and Ratings
Trident Texofab’s performance over the last three years, one year, and three months has been below par relative to the BSE500 index, highlighting persistent underperformance. The company’s Mojo Score stands at 23.0, with a Mojo Grade of Strong Sell as of 3 Feb 2026, an upgrade from the previous Sell rating. The Market Cap Grade is 4, reflecting its relative size and market capitalisation within the sector.
Majority shareholding remains with non-institutional investors, which may influence liquidity and trading patterns. The stock’s day change of -5.00% today further emphasises the ongoing downward pressure.
Holding Trident Texofab Ltd from Garments & Apparels? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Summary of Key Concerns
The stock’s prolonged decline to Rs.49.82, its lowest level in 52 weeks, reflects a combination of weak sales performance, elevated leverage, and sustained negative returns. The company’s financial metrics, including a modest ROCE and high Debt to EBITDA ratio, highlight challenges in capital efficiency and debt servicing capacity. The technical indicators reinforce the bearish momentum, with the stock trading below all major moving averages and exhibiting negative momentum across multiple timeframes.
Market conditions have also been unfavourable, with the Sensex and several sectoral indices experiencing declines and hitting new lows, contributing to a cautious environment for stocks in the Garments & Apparels sector.
Despite these headwinds, valuation metrics suggest the stock is trading at a discount relative to peers, supported by recent profit growth. However, this has not translated into positive price performance, as reflected in the stock’s significant underperformance versus the broader market.
Conclusion
Trident Texofab Ltd’s stock reaching a 52-week low of Rs.49.82 marks a notable point in its recent market journey, characterised by sustained price weakness and challenging financial indicators. The combination of subdued sales, high leverage, and bearish technical signals has contributed to this decline. While valuation metrics offer some relative appeal, the stock remains under pressure amid a broader market downturn and sectoral headwinds.
Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today
